Group One Trading’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,700
Closed -$4.2K 8603
2025
Q1
$4.2K Buy
+1,700
New +$4.04K ﹤0.01% 6726
2024
Q4
Sell
-3,400
Closed -$16.8K 7901
2024
Q3
$16.8K Sell
3,400
-400
-11% -$2.06K ﹤0.01% 5330
2024
Q2
$16.8K Sell
3,800
-61,900
-94% -$290K ﹤0.01% 5332
2024
Q1
$443K Buy
65,700
+32,300
+97% +$245K ﹤0.01% 2860
2023
Q4
$249K Buy
33,400
+25,600
+328% +$218K ﹤0.01% 3663
2023
Q3
$79.3K Buy
+7,800
New +$166K ﹤0.01% 4663

Other funds holding SLRN

Group One Trading's SLRN Position: Q2 2025 in Review

Group One Trading sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 7,662 shares — an estimated $18.9K sold.

Group One Trading first reported a position in SLRN in Q3 2023 and held it in 5 quarters. The position peaked at $132K in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Group One Trading reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 7,662 ACELYRIN shares in Q2 2025, an estimated $18.9K.
  • Group One Trading first reported a position in ACELYRIN in Q3 2023 and held it in 5 quarters.
  • Group One Trading's ACELYRIN position peaked at $132K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.